0
0.5
1
1.5
2+
Death/hospitalization
59%
primary
Improvement
Relative Risk
Death/hospitalization (b)
71%
Mortality
15%
unadjusted
Ventilation
9%
unadjusted
Hospitalization
48%
unadjusted
Progression
42%
unadjusted
Aspirin de Jesús Ascencio-Montiel et al. EARLY TREATMENT
Is early treatment with aspirin + combined treatments beneficial for COVID-19?
Retrospective 28,048 patients in Mexico
Lower death/hosp. (p<0.0001) and hospitalization (p<0.0001)
c19early.org
de Jesús Ascencio-Montiel et al., Arch.., Jan 2022
Favors aspirin
Favors control